chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Tinnitus, Vaccination site pain
Clinical narrative: very high frequency of tinnitus and totally constant, exactly same; arm stiffness and pain at the injection site; stiffness and pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (very high frequency of tinnitus and totally constant, exactly same), MUSCULOSKELETAL STIFFNESS (arm stiffness and pain at the injection site) and VACCINATION SITE PAIN (stiffness and pain at the injection site) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TINNITUS (very high frequency of tinnitus and totally constant, exactly same), MUSCULOSKELETAL STIFFNESS (arm stiffness and pain at the injection site) and VACCINATION SITE PAIN (stiffness and pain at the injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, TINNITUS (very high frequency of tinnitus and totally constant, exactly same), MUSCULOSKELETAL STIFFNESS (arm stiffness and pain at the injection site) and VACCINATION SITE PAIN (stiffness and pain at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity, Peripheral swelling
Clinical narrative: painful arm, and hand; swollen arm and hand; difficult for her to move her hand; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (painful arm, and hand), PERIPHERAL SWELLING (swollen arm and hand) and MOBILITY DECREASED (difficult for her to move her hand) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced PAIN IN EXTREMITY (painful arm, and hand), PERIPHERAL SWELLING (swollen arm and hand) and MOBILITY DECREASED (difficult for her to move her hand). At the time of the report, PAIN IN EXTREMITY (painful arm, and hand), PERIPHERAL SWELLING (swollen arm and hand) and MOBILITY DECREASED (difficult for her to move her hand) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant medications were reported i.e., Thyroid Medication, Glaucoma Medication.  Treatment details are provided i.e., Excedrin, Tylenol, Soak.  Reporter stated she had both doses and she is fine.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Followup was received on 08-Jun-2021. Added dose 2 information. Updated action taken for suspect drug and outcome of events.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Expired product administered, Fatigue, Malaise, Pain in extremity
Clinical narrative: already expired since 23Mar2021; sore arm; taste of food is different; hasn't felt well for awhile; feels tired but not like before; dizziness after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different), MALAISE (hasn't felt well for awhile) and DIZZINESS (dizziness after the first dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Reported.  Concomitant products included IBUPROFEN for Headache, OXCARBAZEPINE (OXTELLAR XR), TOPIRAMATE, LISINOPRIL, HYDROCHLOROTHIAZIDE and LORAZEPAM for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (dizziness after the first dose). On 04-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different) and MALAISE (hasn't felt well for awhile). 04-May-2021, the patient experienced FATIGUE (feels tired but not like before). At the time of the report, EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different), MALAISE (hasn't felt well for awhile), DIZZINESS (dizziness after the first dose) and FATIGUE (feels tired but not like before) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information  was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Non-Significant Follow-up
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: already expired since 23Mar2021; sore arm; taste of food is different; hasn't felt well for awhile; feels tired but not like before; dizziness after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different), MALAISE (hasn't felt well for awhile) and DIZZINESS (dizziness after the first dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 025C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Reported.  Concomitant products included IBUPROFEN for Headache, OXCARBAZEPINE (OXTELLAR XR), TOPIRAMATE, LISINOPRIL, HYDROCHLOROTHIAZIDE and LORAZEPAM for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (dizziness after the first dose). On 04-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different) and MALAISE (hasn't felt well for awhile). 04-May-2021, the patient experienced FATIGUE (feels tired but not like before). At the time of the report, EXPIRED PRODUCT ADMINISTERED (already expired since 23Mar2021), PAIN IN EXTREMITY (sore arm), TASTE DISORDER (taste of food is different), MALAISE (hasn't felt well for awhile), DIZZINESS (dizziness after the first dose) and FATIGUE (feels tired but not like before) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information  was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Non-Significant Follow-up
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity
Clinical narrative: could raise arm to the side; now it hurts; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT ( could raise arm to the side) and PAIN IN EXTREMITY (now it hurts) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included Swollen lymph nodes (swelling in the lymph node (left arm) after receiving the first dose of the Moderna Covid19 vaccine.) and Mammogram (negative.). Concomitant products included ALENDRONATE SODIUM and OMEPRAZOLE for an unknown indication.    On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced LIMB DISCOMFORT ( could raise arm to the side) and PAIN IN EXTREMITY (now it hurts). At the time of the report, LIMB DISCOMFORT ( could raise arm to the side) and PAIN IN EXTREMITY (now it hurts) outcome was unknown. Not Provided          This case was linked to MOD-2021-065472 (E2B Linked Report).; Sender's Comments:  MOD-2021-065472:First Dose Case
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Developed shingles; This spontaneous case was reported by a pharmacist and describes the occurrence of HERPES ZOSTER (Developed shingles) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     Concurrent medical conditions included Shingles. Concomitant products included FOLIC ACID, FERROUS SULFATE, FOLIC ACID (FERROUS SULPHATE + FOLIC ACID), TIMOLOL MALEATE (TIMOLOL MALEATE EX), LATANOPROST and GABAPENTIN for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On an unknown date, the patient experienced HERPES ZOSTER (Developed shingles). At the time of the report, HERPES ZOSTER (Developed shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication were reported.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Initial insomnia, Pain
Clinical narrative: problems to sleep; Body aches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INITIAL INSOMNIA (problems to sleep), PAIN (Body aches) and CHILLS (Chills) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     No medical history information was provided by the reporter.  Concurrent medical conditions included Diabetes.   On 09-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-May-2021, the patient experienced INITIAL INSOMNIA (problems to sleep), PAIN (Body aches) and CHILLS (Chills). At the time of the report, INITIAL INSOMNIA (problems to sleep), PAIN (Body aches) and CHILLS (Chills) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. Concomitant and treatment medication were not provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: she started losing her taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (she started losing her taste) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced AGEUSIA (she started losing her taste). At the time of the report, AGEUSIA (she started losing her taste) outcome was unknown. Not Provided          No concomitant medication reported. No treatment information reported. A week after the second dose patient started losing her taste. Patient  wanted to know it is on and off  if this was normal.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: FU attempt made, consent declined by patient
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Decreased appetite, Diarrhoea
Clinical narrative: loss of appetite; cough,coughing mucus up; CONTINUED CHILLS; chills; Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), DIARRHOEA (Diarrhea), DECREASED APPETITE (loss of appetite), COUGH (cough,coughing mucus up) and CHILLS (CONTINUED CHILLS) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced CHILLS (chills) and DIARRHOEA (Diarrhea). On 10-May-2021, the patient experienced DECREASED APPETITE (loss of appetite), COUGH (cough,coughing mucus up) and CHILLS (CONTINUED CHILLS). On 08-May-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, CHILLS (chills), DECREASED APPETITE (loss of appetite), COUGH (cough,coughing mucus up) and CHILLS (CONTINUED CHILLS) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment details were provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: rash on right leg, than spread on left leg; red rash; itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on right leg, than spread on left leg), RASH ERYTHEMATOUS (red rash) and RASH PRURITIC (itchy rash) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 006C21A.) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, HYDROCHLOROTHIAZIDE and VITAMIN D NOS for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 ml. On 05-May-2021, the patient experienced RASH (rash on right leg, than spread on left leg), RASH ERYTHEMATOUS (red rash) and RASH PRURITIC (itchy rash). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, RASH (rash on right leg, than spread on left leg), RASH ERYTHEMATOUS (red rash) and RASH PRURITIC (itchy rash) outcome was unknown.            Treatment includes Hydrocortisone Cream
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: Lesion in the injection site as a "magnetic tag"; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Lesion in the injection site as a "magnetic tag") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (Lesion in the injection site as a "magnetic tag"). At the time of the report, VACCINATION SITE REACTION (Lesion in the injection site as a "magnetic tag") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment Information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: less than half of second dose administered to patient; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (less than half of second dose administered to patient) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to dosage form. On 10-May-2021, the patient experienced INCORRECT DOSE ADMINISTERED (less than half of second dose administered to patient). At the time of the report, INCORRECT DOSE ADMINISTERED (less than half of second dose administered to patient) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported. Action taken with mRNA-123 is not applicable.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Mass, Pain, Swelling
Clinical narrative: swelling in my arm pit; It is look like a lump; It is soft and sore; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling in my arm pit), MASS (It is look like a lump) and PAIN (It is soft and sore) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. D27C21A and 032B21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced SWELLING (swelling in my arm pit), MASS (It is look like a lump) and PAIN (It is soft and sore). At the time of the report, SWELLING (swelling in my arm pit), MASS (It is look like a lump) and PAIN (It is soft and sore) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included Thyroid medications, Estrogen medication and Antidepressant for unknown indication. No treatment was received by the patient.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchy spot at injection site; Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy spot at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-May-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy spot at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy spot at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease, Nausea, Rhinorrhoea
Clinical narrative: nausea; nasal drip; acid reflux to the point that she cant eat or look at pictures of food; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-May-2021 and was forwarded to Moderna on 10-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), RHINORRHEA (nasal drip) and GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux to the point that she cant eat or look at pictures of food) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced NAUSEA (nausea), RHINORRHEA (nasal drip) and GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux to the point that she cant eat or look at pictures of food). At the time of the report, NAUSEA (nausea), RHINORRHEA (nasal drip) and GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux to the point that she cant eat or look at pictures of food) outcome was unknown. Not Provided          No concomitant medication details was reported. No treatment medication details was reported.   This case was linked to MOD-2021-053003 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased, Presyncope, Vaccination site warmth
Clinical narrative: dizzy; fast heart rate; almost passed out; hot flashes AT INJECTION SITE; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), HEART RATE INCREASED (fast heart rate), PRESYNCOPE (almost passed out) and VACCINATION SITE WARMTH (hot flashes AT INJECTION SITE) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy), HEART RATE INCREASED (fast heart rate), PRESYNCOPE (almost passed out) and VACCINATION SITE WARMTH (hot flashes AT INJECTION SITE). At the time of the report, DIZZINESS (dizzy), HEART RATE INCREASED (fast heart rate) and PRESYNCOPE (almost passed out) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    No treatment information was reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Paraesthesia, Vision blurred
Clinical narrative: Pins and needles sensation in hands and feet; Headache; Hazy vision; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA (Pins and needles sensation in hands and feet), HEADACHE (Headache) and VISION BLURRED (Hazy vision) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     Concurrent medical conditions included Enlarged thyroid.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced PARAESTHESIA (Pins and needles sensation in hands and feet), HEADACHE (Headache) and VISION BLURRED (Hazy vision). At the time of the report, PARAESTHESIA (Pins and needles sensation in hands and feet), HEADACHE (Headache) and VISION BLURRED (Hazy vision) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission in error
Clinical narrative: exceeded the time frame between doses,Missed the second dose; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION IN ERROR (exceeded the time frame between doses,Missed the second dose) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION IN ERROR (exceeded the time frame between doses,Missed the second dose). At the time of the report, PRODUCT DOSE OMISSION IN ERROR (exceeded the time frame between doses,Missed the second dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Fatigue, Headache, Malaise, Pain in extremity
Clinical narrative: very sore in left arm; she had not been feeling well for past day and half; fatigue; headache; Dose of COVID-19 vaccine had been drawn up in the syringe from Friday 07May2021 and this; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose of COVID-19 vaccine had been drawn up in the syringe from Friday 07May2021 and this), PAIN IN EXTREMITY (very sore in left arm), MALAISE (she had not been feeling well for past day and half), FATIGUE (fatigue) and HEADACHE (headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No specified medical history has been reported.     On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose of COVID-19 vaccine had been drawn up in the syringe from Friday 07May2021 and this). On an unknown date, the patient experienced PAIN IN EXTREMITY (very sore in left arm), MALAISE (she had not been feeling well for past day and half), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose of COVID-19 vaccine had been drawn up in the syringe from Friday 07May2021 and this), PAIN IN EXTREMITY (very sore in left arm), MALAISE (she had not been feeling well for past day and half), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2021: Additional information  received on 18 Jul 2021 contain , patient detail
Age: 17.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: We gave the Moderna Covid-19 vaccine to someone that's 17yrs old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (We gave the Moderna Covid-19 vaccine to someone that's 17yrs old) in a 17-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (We gave the Moderna Covid-19 vaccine to someone that's 17yrs old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (We gave the Moderna Covid-19 vaccine to someone that's 17yrs old) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant and treatment details were provided.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Product dose omission issue
Clinical narrative: 2nd dose delayed beyond 42 days; Sick after the 1st dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose delayed beyond 42 days) and ILLNESS (Sick after the 1st dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose delayed beyond 42 days) and ILLNESS (Sick after the 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (2nd dose delayed beyond 42 days) and ILLNESS (Sick after the 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant  information was  provided. No Treatment information was  provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Illness, Lymphadenopathy
Clinical narrative: Very Sick; Solid Lymph Nodes; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very Sick) and LYMPHADENOPATHY (Solid Lymph Nodes) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ILLNESS (Very Sick) and LYMPHADENOPATHY (Solid Lymph Nodes). At the time of the report, ILLNESS (Very Sick) and LYMPHADENOPATHY (Solid Lymph Nodes) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information given by the reporter.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Dizziness
Clinical narrative: Dizziness after the first dose; bad reaction for 2 hours after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness after the first dose) and ADVERSE DRUG REACTION (bad reaction for 2 hours after the first dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042B21A and 025C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LORAZEPAM for Dental treatment NOS, IBUPROFEN for Headache, OXCARBAZEPINE (OXTELLAR XR), TOPIRAMATE, LISINOPRIL and HYDROCHLOROTHIAZIDE for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced DIZZINESS (Dizziness after the first dose) and ADVERSE DRUG REACTION (bad reaction for 2 hours after the first dose). At the time of the report, DIZZINESS (Dizziness after the first dose) and ADVERSE DRUG REACTION (bad reaction for 2 hours after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-114547 (E2B Linked Report). This case was linked to MOD-2021-116427 (Patient Link).; Sender's Comments:  MOD-2021-114547:Son's Case
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Joint injury, Pain in extremity
Clinical narrative: he fell and broke his elbow; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and JOINT INJURY (he fell and broke his elbow) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for Blood pressure, MELOXICAM for Pain, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL PALMITATE, RIBOFLAVIN, THIAMINE MONONITRATE (MULTIVITAMIN 6) and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 18-Feb-2021, the patient experienced JOINT INJURY (he fell and broke his elbow). The patient was treated with Surgery for Joint injury. On 15-Feb-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, JOINT INJURY (he fell and broke his elbow) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    This case was linked to MOD-2021-116476 (Patient Link).
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Treatment noncompliance
Clinical narrative: Patient did not get 2nd dose on the due date; Patient possibly getting 2nd dose after 42 days of getting the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not get 2nd dose on the due date) and TREATMENT NONCOMPLIANCE (Patient possibly getting 2nd dose after 42 days of getting the 1st dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04UA21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not get 2nd dose on the due date) and TREATMENT NONCOMPLIANCE (Patient possibly getting 2nd dose after 42 days of getting the 1st dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not get 2nd dose on the due date) and TREATMENT NONCOMPLIANCE (Patient possibly getting 2nd dose after 42 days of getting the 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-116509 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-116509:Wife case
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     Concurrent medical conditions included Food allergy and Seasonal allergy.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No relevant concomitant medications were reported.  Patient stated that after taking Advil (ibuprofen) she felt much better.   This case was linked to MOD-2021-116441 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up attached on 09JUL2021 (TCR form) had treatment medication updated.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: 3 sick for 2 weeks after the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick for 2 weeks after the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick for 2 weeks after the Moderna vaccine). At the time of the report, ILLNESS (sick for 2 weeks after the Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021:
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Myalgia, Night sweats, Pain in extremity
Clinical narrative: big red area over the injection site.; night sweats; arm sore; chills; fever; bodyache; I felt awful; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (I felt awful), NIGHT SWEATS (night sweats), PAIN IN EXTREMITY (arm sore), CHILLS (chills) and PYREXIA (fever) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced FEELING ABNORMAL (I felt awful), CHILLS (chills), PYREXIA (fever) and MYALGIA (bodyache). 08-May-2021, the patient experienced PAIN IN EXTREMITY (arm sore). On 09-May-2021, the patient experienced NIGHT SWEATS (night sweats). On 10-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (big red area over the injection site.). At the time of the report, FEELING ABNORMAL (I felt awful), NIGHT SWEATS (night sweats), PAIN IN EXTREMITY (arm sore), CHILLS (chills), PYREXIA (fever), MYALGIA (bodyache) and VACCINATION SITE ERYTHEMA (big red area over the injection site.) outcome was unknown. Not Provided          Treatment information was not provided. Concomitant product use was not provided
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema
Clinical narrative: big red area over the injection site.; night sweats; arm sore; chills; fever; bodyache; I felt awful; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (I felt awful), NIGHT SWEATS (night sweats), PAIN IN EXTREMITY (arm sore), CHILLS (chills) and PYREXIA (fever) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced FEELING ABNORMAL (I felt awful), CHILLS (chills), PYREXIA (fever) and MYALGIA (bodyache). 08-May-2021, the patient experienced PAIN IN EXTREMITY (arm sore). On 09-May-2021, the patient experienced NIGHT SWEATS (night sweats). On 10-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (big red area over the injection site.). At the time of the report, FEELING ABNORMAL (I felt awful), NIGHT SWEATS (night sweats), PAIN IN EXTREMITY (arm sore), CHILLS (chills), PYREXIA (fever), MYALGIA (bodyache) and VACCINATION SITE ERYTHEMA (big red area over the injection site.) outcome was unknown. Not Provided          Treatment information was not provided. Concomitant product use was not provided
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypoaesthesia, Paraesthesia, Product dose omission issue, Vaccination site pain
Clinical narrative: More than 36 days after the first dose without receiving second dose; tingling in both arms and hands; numbness in both arms and hands; "feels like when your leg falls asleep"; soreness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness in both arms and hands), FEELING ABNORMAL ("feels like when your leg falls asleep"), PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving second dose), PARAESTHESIA (tingling in both arms and hands) and VACCINATION SITE PAIN (soreness at the injection site) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness at the injection site). On 26-Apr-2021, the patient experienced HYPOAESTHESIA (numbness in both arms and hands), FEELING ABNORMAL ("feels like when your leg falls asleep") and PARAESTHESIA (tingling in both arms and hands). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving second dose). At the time of the report, HYPOAESTHESIA (numbness in both arms and hands), FEELING ABNORMAL ("feels like when your leg falls asleep"), PRODUCT DOSE OMISSION ISSUE (More than 36 days after the first dose without receiving second dose), PARAESTHESIA (tingling in both arms and hands) and VACCINATION SITE PAIN (soreness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Myalgia, Vertigo
Clinical narrative: Vertigo with first shot; body aches like the flu after the first dose; body aches like the flu after the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo with first shot), INFLUENZA (body aches like the flu after the first dose) and MYALGIA (body aches like the flu after the first dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PROBIOTICS NOS, VITAMINS NOS and VITAMIN B NOS for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Vertigo with first shot), INFLUENZA (body aches like the flu after the first dose) and MYALGIA (body aches like the flu after the first dose). At the time of the report, VERTIGO (Vertigo with first shot), INFLUENZA (body aches like the flu after the first dose) and MYALGIA (body aches like the flu after the first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included Atrial fibrillation medications, Blood pressure medications, Thyroid medications, Reflux medications, Antidepressants, ADHD medications. No treatment information reported.   This case was linked to MOD-2021-116489 (Patient Link).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis chronic, Cough, Dyspnoea, Headache, Neck pain
Clinical narrative: shortness of breath/difficulty breathing; bronchitis cough; chronic bronchitis; pelvic pain; neck hurts to move; sore throat; Difficulty breathing; Really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath/difficulty breathing), COUGH (bronchitis cough), BRONCHITIS CHRONIC (chronic bronchitis), PELVIC PAIN (pelvic pain) and NECK PAIN (neck hurts to move) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ALBUTEROL SULFATE, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), BUSPIRONE, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), PANTOPRAZOLE, LAMOTRIGINE, LORATADINE (CLARITIN [LORATADINE]) and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-May-2021, the patient experienced HEADACHE (Really bad headache). On 09-May-2021, the patient experienced DYSPNOEA (shortness of breath/difficulty breathing), COUGH (bronchitis cough), BRONCHITIS CHRONIC (chronic bronchitis), PELVIC PAIN (pelvic pain), NECK PAIN (neck hurts to move), OROPHARYNGEAL PAIN (sore throat) and DYSPNOEA (Difficulty breathing). At the time of the report, DYSPNOEA (shortness of breath/difficulty breathing), COUGH (bronchitis cough), BRONCHITIS CHRONIC (chronic bronchitis), PELVIC PAIN (pelvic pain), NECK PAIN (neck hurts to move), OROPHARYNGEAL PAIN (sore throat), DYSPNOEA (Difficulty breathing) and HEADACHE (Really bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.